Is the price fair?
What LFST's price assumes
LifeStance Health Group, Inc. trades at 98.4× earnings against 19.6× for the median Medical Care Facilities name, more expensive than its own group.
98.4
Trailing P/E · Medical Care Facilities median 19.6 · 5.03× the median: the market pays up for this one
- Price / sales
- 1.68
Price / sales · as of 2026-Q1
- Free cash flow yield
- 4.6%
Free cash flow yield · Medical Care Facilities median 7.1%
- Growth the price implies
- +6.7%
Growth the price implies · The price pays for +6.7% free cash flow growth a year for a decade; revenue has grown +18% a year over the last three.
Details›
- Price / book2026-Q1
- 1.70
- EV / EBIT2026-Q1
- 58.1
- EV / sales2026-Q1
- 1.74
- Healthcare median P/E362 names
- 29.9
- Medical Care Facilities median P/E29 names
- 19.6
- Free cash flow, trailing twelve months
- $174M
- Market capitalisation
- $3.77B
- 3-year revenue growth
- +18%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.